France· FR:67263268
ALTUVOCT 250 UI, poudre et solvant pour solution injectable
A efanesoctocog alfa product containing éfanésoctocog alfa, registered in France by SWEDISH ORPHAN BIOVITRUM (SUEDE). The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Efanesoctocog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD45 (efanesoctocog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Efanesoctocog alfa · ATC B02BD45
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ÉFANÉSOCTOCOG ALFA
- Manufacturer
- SWEDISH ORPHAN BIOVITRUM (SUEDE)
- Country
- France (FR)
- ATC code
- B02BD45
- ATC class
- Efanesoctocog alfa
- Defined daily dose
- 500 E, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302972301 flacon en verre de 250 UI + 1 seringue préremplie en verre de 3 mL + 1 tige de piston + 1 adaptateur pour flacon + 1 set de perfusion
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efanesoctocog alfa in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandALTUVOCTOrifarm Oy
- SwitzerlandAltuvoct
- CzechiaALTUVOCTSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALTUVOCT 1 000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- SwedenALTUVOCT 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- NorwayAltuvoctSwedish Orphan Biovitrum AB
- PolandAltuvoctSwedish Orphan Biovitrum AB (publ)
- BelgiumAltuvoct 1000 IUSwedish Orphan Biovitrum (Publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Altuvoct
- Liechtenstein · Altuvoct
- Norway · Altuvoct
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbff865a-07ee-45af-833e-92997ac88d85 GET /v1/drugs/dbff865a-07ee-45af-833e-92997ac88d85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67263268",
"date_amm": "2024-06-17",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1824",
"substance": "ÉFANÉSOCTOCOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about efanesoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.